M&A Update – Aug 18

– SHCO to be acquired by MCR for $9.00 cash per share, 83.3% premium, $2.7 billion
– YEXT received an unsolicited acquisition proposal from its CEO for $9.00 cash per share
– YMAB / SERB Pharmaceuticals launched tender offer, expires Sept 15, filed HSR Aug 15
– VRNA / MRK filed DEFM14a, vote Sept 24, filed HSR Aug 5, closing Q4 2025
– THTX / Future Pak filed management information circular, vote Sept 12
– MTAL / HMY cleared Australia FIRB, satisfied all regulatory conditions
– ZIMV / ARCHIMED filed PREM14a, filed HSR Aug 15, closing by year end 2025
– CIO / MCME Carell Holdings, LP (Elliott / Morning Calm Management) announced first closing of Phoenix portfolio sale
– CRGX tender expires
– STR vote
– SPTN HSR expires
– OLO HSR expires